Literature DB >> 15203142

Novel delta2-isoxazolines as group II phospholipase A2 inhibitors.

M Satish Kumar, S Nanjunda Swamy, M Mahendra, J Shashidhara Prasad, B S Viswanath, K S Rangappa.   

Abstract

The synthesized imidazolyl substituted delta2-isoxazolines were subjected to Phospholipase A(2) (PLA(2)) enzyme inhibitory activity against snake venom source and their structure-activity relationship with respect to different groups attached to this moiety is reported for the first time. The crystal structure of the compound 2-butyl-5-chloro-3H-imidazolyl-4-carbaldehyde oxime 2, an intermediate for the construction of isoxazolines is reported. These compounds exerted a significant PLA(2) enzyme inhibitory activity against group II PLA(2). The in vivo activity on mice of selected compounds 3bI and 3bIV shows the comparable anti-inflammatory activity with the known standard ursolic acid.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203142     DOI: 10.1016/j.bmcl.2004.05.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Novel apigenin based small molecule that targets snake venom metalloproteases.

Authors:  Venkatachalaiah Srinivasa; Mahalingam S Sundaram; Sebastian Anusha; Mahadevappa Hemshekhar; Siddaiah Chandra Nayaka; Kempaiah Kemparaju; Kesturu S Girish; Kanchugarakoppal S Rangappa
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

2.  Synthesis and antiinflammatory activity of newer pyrazolinylbenzidines and isoxazolinylbenzidines.

Authors:  S Sharma; K K Saxena
Journal:  Indian J Pharm Sci       Date:  2014-07       Impact factor: 0.975

3.  Investigation of NPB Analogs That Target Phosphorylation of BAD-Ser99 in Human Mammary Carcinoma Cells.

Authors:  Swamy Savvemala Girimanchanaika; Dukanya Dukanya; Ananda Swamynayaka; Divya Maldepalli Govindachar; Mahendra Madegowda; Ganga Periyasamy; Kanchugarakoppal Subbegowda Rangappa; Vijay Pandey; Peter E Lobie; Basappa Basappa
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

4.  Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives.

Authors:  Fernanda Virginia Barreto Mota; Marlene Saraiva de Araújo Neta; Eryvelton de Souza Franco; Isla Vanessa Gomes Alves Bastos; Larissa Cardoso Correia da Araújo; Sandra Cabral da Silva; Tatiane Bezerra de Oliveira; Eduarda Karynne Souza; Valderes Moraes de Almeida; Rafael Matos Ximenes; Maria Bernadete de Sousa Maia; Francisco Jaime Bezerra Mendonça Junior; Pascal Marchand; Antônio Rodolfo de Faria; Teresinha Gonçalves da Silva
Journal:  Medchemcomm       Date:  2019-09-12       Impact factor: 3.597

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.